Brain perfusion anomalies in rapid eye movement sleep behavior disorder with mild cognitive impairment

Movement Disorders

Volumn 27, Issue 10, 2012, Pages 1255-1261

  Vendette, Mélanie ^a,b   Montplaisir, Jacques ^a,b   Gosselin, Nadia ^a,b   Soucy, Jean Paul ^c,d   Postuma, Ronald B ^e   Dang Vu, Thien Thanh ^a,f   Gagnon, Jean Franccois ^a,g  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MONTREAL GENERAL HOSPITAL   (Canada)

^f UNIVERSITY OF LIÈGE   (Belgium)

^g UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Lewy body dementia; Mild cognitive impairment; Parkinson's disease; REM sleep behavior disorder; SPECT (regional cerebral blood flow)

Indexed keywords

ETHYLENE CYSTEINATE TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRAIN PERFUSION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGY; OCCIPITAL CORTEX; PARACENTRAL GYRUS; PARAHIPPOCAMPAL GYRUS; PARIETAL CORTEX; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PUTAMEN; REM SLEEP; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DISORDER; TEMPORAL CORTEX;

AGED; BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; CYSTEINE; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGANOTECHNETIUM COMPOUNDS; PERFUSION; POLYSOMNOGRAPHY; RADIOPHARMACEUTICALS; REM SLEEP BEHAVIOR DISORDER; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84866297063     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25034     Document Type: Article

References (42)

1. Gagnon JF, Postuma RB, Mazza S, Doyon J, Montplaisir J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol. 2006; 5: 424-432.
2. Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009; 72: 1296-1300.
3. Iranzo A, Molinuevo JL, Santamaría J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006; 5: 572-577.
4. Gagnon JF, Vendette M, Postuma RB, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann Neurol. 2009; 66: 39-47.
5. Gauthier S, Reisberg B, Zaudig M, et al. International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild cognitive impairment. Lancet. 2006; 367: 1262-1270.
6. Mazza S, Soucy JP, Gravel P, et al. Assessing whole brain perfusion changes in patients with REM sleep behavior disorder. Neurology. 2006; 67: 1618-1622.
7. Vendette M, Gagnon JF, Soucy JP, et al. Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder. Mov Disord. 2011; 26: 1717-1724.
8. Hanyu H, Inoue Y, Sakurai H, et al. Regional cerebral blood flow changes in patients with idiopathic REM sleep behavior disorder. Eur J Neurol. 2011; 18: 784-788.
9. Caselli RJ, Chen K, Bandy D, et al. A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior. Sleep. 2006; 29: 927-933.
10. Montplaisir J, Gagnon JF, Fantini ML, et al. Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord. 2010; 25: 2044-2051.
11. American Academy of Sleep Medicine, Task Force Chair; Hauri PJ, Chairman. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. (4th ed revised). Washington, DC: American Psychiatric Press, 2000.
13. Fahn S, Elton R. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. II. New York: 1987; 153-163.
14. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques And Scoring System for Sleep Stages of Human Subjects. Washington, DC: Public Health Service, US Government Printing Office; 1968.
15. Folstein MF, Folstein SE, McHugh PR. Mini Mental State: a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res. 1975; 12: 189-198.
16. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: Harcourt Brace & Company; 1997.
17. Army Individual Test Battery: Manual of Directions and Scoring. Washington, DC: War Department, Adjutant General's Office; 1944.
18. Bohnen N, Jolles J, Twijnstra A. Modification of the Stroop color word test improves differentiation between patients with mild head injury and matched controls. Clin Neuropsychol. 1992; 6: 178-184.
19. Benton AL, Sivan AB, Hamsher K, et al. Contributions to Neuropsychological Assessment. New York: Oxford University Press; 1983.
20. Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France; 1964.
21. Osterrieth PA. Le test de copie d'une figure complexe: contribution à l'étude de la perception et de la mémoire. Arch Psychol. 1944; 30: 286-356.
22. Gauthier L, Dehaut F, Joanette Y. The bells test: a quantitative and qualitative test for visual neglect. Int J Clin Neuropsychol. 1989; 22: 49-54.
23. Cistaro A, Valentini MC, Chiò A, et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging. 2012; 39: 251-259.
24. Morbelli S, Rodriguez G, Mignone A, et al. The need of appropriate brain SPECT templates for SPM comparisons. Q J Nucl Med Mol Imaging. 2008; 52: 89-98.
25. Brett M, Penny W, Kiebel SJ. An introduction to random field theory. In: Frackowiak RS, Friston KJ, Frith C, Dolan RJ, Price CJ, Zeki S, et al., eds. Human Brain Function. San Diego: CA: Academic; 2004.
26. Nobili F, Abbruzzese G, Morbelli S, et al. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study. Mov Disord. 2009; 24: 414-421.
27. Kasama S, Tachibana H, Kawabata K, Yoshikawa H. Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging. Dement Geriatr Cogn Disord. 2005; 19: 266-275.
28. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage. 2003; 20: 1309-1319.
29. Colloby SJ, Fenwick JD, Williams ED, et al. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging. 2002; 29: 615-622.
30. Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Brain. 2008; 131: 690-705.
31. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain. 2004; 127: 791-800.
32. Lee JE, Park HJ, Park B, et al. A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2010; 81: 320-326.
33. Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci. 2001; 22: 45-46.
34. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989; 12: 366-375.
35. Scherfler C, Frauscher B, Schocke M, et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol. 2011; 69: 400-407.
36. Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med. 1999; 40: 1583-1589.
37. Putcha D, Brickhouse M, O'Keefe K, et al. Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults. J Neurosci. 2011; 31: 17680-17688.
38. Miller SL, Fenstermacher E, Bates J, et al. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. J Neurol Neurosurg Psychiatry. 2008; 79: 630-635.
39. Dai W, Lopez OL, Carmichael OT, et al. Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology. 2009; 250: 856-866.
40. Firbank MJ, Burn DJ, McKeith IG, O'Brien JT. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies. Int J Geriatr Psychiatry. 2005; 20: 776-782.
41. Huang C, Tang C, Feigin A, et al. Changes in network activity with the progression of Parkinson's disease. Brain. 2007; 130: 1834-1846.
42. Tang CC, Poston KL, Dhawan V, Eidelberg D. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci. 2010; 30: 1049-1056.